Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

Vimentin is a type III intermediate filament (IF) protein normally expressed in cells that develop into connective tissue, ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner.

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

However, mechanistic studies to support the conclusion that mitochondrial function is increased in the tumours remain incomplete and would benefit from experiments that would directly interrogate ...

Researchers have identified the transfer of mitochondria with mutated DNA from cancer cells to immune cells as a key ...

What we’ve done is create an instrument where your hands don’t need to be inside the body,” said Dr. David Wazer. “It can be ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

Bolt Biotherapeutics, Inc., announced today that the target of their worldwide co-development collaboration with Toray Industries, Inc. is Caprin-1, a novel cancer target discovered by Toray. The ...

New research has found that changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth.

17."At eight years old, I got my period. Obviously concerned about how young I was, my mom took me to the doctor. The doctor ...

Vimentin is a type III intermediate filament (IF) protein typically expressed in cells that differentiate into connective ...